Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development
Tadahito Yasuda, Yanru Wang
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 627-642
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer
Huai Li, Xu Chen, Shanshan Zheng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Signature Construction Associated with Tumor-Infiltrating Macrophages Identifies IRF8 as a Novel Biomarker for Immunotherapy in Advanced Gastric Cancer
Wanqian Liao, Yu Wang, Rui Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1089-1089
Open Access
Discussion on the mechanism of HER2 resistance in esophagogastric junction and gastric cancer in the era of immunotherapy
Yan Zhang, Wenxuan Fan, Fei Su, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
A Single-Cell Approach to Analyzing Vascular Endothelial Cell Contributions in VEGF-Driven Angiogenesis and LINC02313 in Gastric Cancer
Morteza Hadizadeh, Nahid Askari, Saeideh Jafarinejad‐Farsangi
Computational Biology and Chemistry (2025) Vol. 115, pp. 108361-108361
Closed Access
Gastric biopsy-derived cell line and its utility in assessing tumor cell drug sensitivity
Masato Hayashi, Rei Noguchi, Makoto Abe, et al.
Biomedical Research (2025) Vol. 46, Iss. 1, pp. 27-35
Open Access
BTK inhibitors are a possible emerging therapeutic target for gastric cancer
José Darío Portillo‐Miño, Jhon Jairo Calderon, Arnoldo Riquelme
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200935-200935
Closed Access
Research and analysis of circulating tumor cell detection in the diagnosis and treatment of gastric cancer
Hong Ji
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
The enigma of maladaptation in gastric pathophysiology
Gunter Maubach, Anumantha G. Kanthasamy, Sudhanshu Gogia, et al.
Trends in cancer (2025)
Open Access
Biological Activity of Peptide Fraction Derived from Hermetia illucens L. (Diptera: Stratiomyidae) Larvae Haemolymph on Gastric Cancer Cells
Roberta Rinaldi, Simona Laurino, Rosanna Salvia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1885-1885
Open Access
A Novel Prognostic Marker Based on Metabolic Gene for Gastric Cancer Patients Receiving Immunotherapy
Hao Xu, Xiaohuan Yuan, Xin Song, et al.
(2025)
Closed Access
Imaging gastric cancer metastasis progression in an organotypic, three-dimensional functional model of the human peritoneum
Arianna Castagna, Frank‐Jürgen Weinreich, Andreas Brandl, et al.
Pleura and Peritoneum (2025) Vol. 10, Iss. 1, pp. 11-17
Open Access
Nanomaterials in gastric cancer: pioneering precision medicine for diagnosis, therapy, and prevention
Tiantian Liu, Ying-Qiu Gu, Zaili Yang, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Integrative analysis of single-cell and bulk RNA sequencing reveals the oncogenic role of ANXA5 in gastric cancer and its association with drug resistance
Denggang Chen, Peng Zhang, Li Gong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Comprehensive Analysis of Potential Common Pathogenic Mechanisms for COVID‐19 Infection and Gastric Cancer
Guiqian Zhang, Ning Wang, Shi‐Xun Ma, et al.
Analytical Cellular Pathology (2025) Vol. 2025, Iss. 1
Open Access
Prognostic and immunological implications of protein kinases in gastric cancer: a focus on hub gene ABL2 and its impact on the polarization of M2 macrophages
Di Chen, Ju Huang, Aiming Yang, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
Integrative network pharmacology, transcriptomics, and proteomics reveal the material basis and mechanism of the Shen Qing Weichang Formula against gastric cancer
Yi Wang, Xiaoyu Sun, Mingming Ren, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Comprehensive Analyses of Single-Cell and Bulk RNA Sequencing Data From M2 Macrophages to Elucidate the Immune Prognostic Signature in Patients with Gastric Cancer Peritoneal Metastasis
Qiao Tang, Liang Tang, Xiaofeng Wang, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 383-402
Open Access
A Mitochondrion‐Targeted NIR‐II Modulator for Synergistic Ferroptosis–Immunotherapy
Miao Wang, Qihang Ding, Wuyue Su, et al.
Small (2025)
Closed Access
Phase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: The role of M2 macrophage landscape in predicting response
Thierry Alcindor, James Tankel, Pierre Fiset, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 4, pp. 102045-102045
Open Access
Nanomaterials in the diagnosis and treatment of gastrointestinal tumors: New clinical choices and treatment strategies
Liping Chen, Qingqing Li
Materials Today Bio (2025), pp. 101782-101782
Open Access
The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates
Liuyue Kan, Yingyan Yu, Yan‐Jiang Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Design, Synthesis and Biological Evaluation of Novel Indole-Capped Histone Deacetylase 6 Inhibitors as Anti-Gastric Cancer Agents
Liying Ma, Xinhui Zhang, Haiqian Nie, et al.
(2025)
Closed Access
Deciphering of intra‐tumoural heterogeneity and the interplay between metastasis‐associated meta‐program and myofibroblasts in gastric cancer
Xiongyan Wu, Zhijian Jin, Baolong Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 5
Open Access
Enhanced cytotoxicity of T-DM1 in HER2-low carcinomas via autophagy inhibition
Jinghui Zhang, Xusheng Chang, Yun Bai, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322029-e0322029
Open Access
CAF-derived miR-642a-3p supports migration, invasion, and EMT of hepatocellular carcinoma cells by targeting SERPINE1
Shuo Zhang, Gang Cao, Shuijie Shen, et al.
PeerJ (2024) Vol. 12, pp. e18428-e18428
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top